Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Tekni-Plex announces new Senior VP and General Manager
Tekni-Plex announces new Senior VP and General Manager
Joseph Horn has joined the company as Senior Vice President and General Manager of its Tekni-Films global business unit
PureTech Health appoints new CMO
PureTech Health appoints new CMO
PureTech Health has appointed Atul Pande, former SVP at GlaxoSmithKline, as Chief Medical Officer
Nanobiotix appoints new Chief Operating Officer
Nanobiotix appoints new Chief Operating Officer
Oncology industry veteran to oversee operations and product commercialisation
Genmab appoints new CDO
Genmab appoints new CDO
Genmab appoints Judith Klimovsky as Executive Vice President and Chief Development Officer (CDO).
Teijin Pharma elects new President
Teijin Pharma elects new President
Teijin Pharma, the core company of the Teijin Group’s healthcare business, has elected Akihisa Nabeshima as President
Lock Inspection appoints international pharmaceutical business manager
Lock Inspection appoints international pharmaceutical business manager
Inspection equipment specialist Lock Inspection (part of Loma Systems) has recently appointed James Chrismas as International Pharmaceutical Business Manager
Glythera appoints Scientific Advisory Board
Glythera appoints Scientific Advisory Board
First members Morris Rosenberg and Robert Lutz will support and advance the company's ADC development pipeline
Moberg CEO divests shares
Moberg CEO divests shares
Peter Wolpert, founder and CEO of Moberg Pharma, has divested 164,601 shares in Moberg Pharma and remains large long-term shareholder
Biosys appoints Axel Wiest to Board of Directors
Biosys appoints Axel Wiest to Board of Directors
Biosys, a clinical-stage microbiome company, is pleased to announce that Axel Wiest has joined the board of the company
Amunix appoints Fred Hausheer as CMO
Amunix appoints Fred Hausheer as CMO
Amunix has announced that it has appointed Frederick Hausheer as its Chief Medical Officer
High Force Research expands business with new appointment
High Force Research expands business with new appointment
UK chemical research and development company High Force Research, has appointed Newcastle University postgraduate Jennifer Wallis to its Business Development team
Novartis appoint Haseeb Ahmad as MD, UK and Ireland
Novartis appoint Haseeb Ahmad as MD, UK and Ireland
Ahmad has also been appointed Country President UK and will be a member of the Novartis European Executive Committee
Almac appoints new VP, UK Operations
Almac appoints new VP, UK Operations
Almac Diagnostics has announced the appointment of Leeona Galligan to the position of Vice President, UK Operations
John Jenkins joins Greenleaf Health
John Jenkins joins Greenleaf Health
Greenleaf Health hires FDA veteran to lead drug and biological products team as Principal, Drug and Biological Products
Infors appoints new CEO of US subsidiary
Infors appoints new CEO of US subsidiary
Experienced business leader Peter Tunon will join the Swiss company
Nelipak Healthcare Packaging makes new appointments and investments
Nelipak Healthcare Packaging makes new appointments and investments
To meet recent growth it has made several appointments and is looking to expand its Costa Rican facility
Previous
1
…
84
85
86
87
(current)
88
89
90
…
216
Next
Trending Articles
Gerresheimer names new Chairman of the Supervisory Board
This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe
Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer
Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach
Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer
Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy
Hovione appoints Stefan Doboczky as Chief Executive Officer
Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all